US Pharma MarketingThe post Edwards lifts FY26 growth outlook following steady Q2 performance appeared first on Medical Device Network.
Edwards lifts FY26 growth outlook following steady Q2 performance
Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its 2026 revenue growth outlook. The post Edwards lifts FY26 growth outlook following steady Q2 performance appeared first on Medical Device Network .
Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its 2026 revenue growth outlook.
Source: Medical Device Network